Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 15.86 is 100% below its estimated 5-year average of 16682.42, near the low end of its estimated 5-year range (0.43–426448.25).
As of 2026-10-06T19:53:12.284Z. 467.71% above its estimated 12-month average of 2.79.
Calculation as of: 2026-10-06T19:53:12.284Z.
Quote observation: 2026-10-06T19:50:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7cda135bbdc40ab96f6f5c38083b7dd78a9f140dcd8a254691991f8eaa2b9dc4
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
15.86
PS RATIO AVG TTM
2.79
PS RATIO AVG 3Y
52.88
PS RATIO AVG 5Y
16682.42
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+467.71%
CURRENT VS 3Y AVG
-70.01%
CURRENT VS 5Y AVG
-99.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.26
median of 579 covered companies
CURRENT VS SECTOR MEDIAN
+272.30%
vs the sector median at left
Neuphoria Therapeutics Inc.
Market Cap
$18.62M
PS Ratio
15.86
TTM Avg
2.79
3Y Avg
52.88
5Y Avg
16682.42
Market Cap
$17.14M
PS Ratio
1.30
TTM Avg
1.77
3Y Avg
177.00
5Y Avg
2050.99
Market Cap
$20.16M
PS Ratio
N/A
TTM Avg
252.77
3Y Avg
5169.56
5Y Avg
5169.56
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.62M | 15.86 | 2.79 | 52.88 | 16682.42 |
| Cosmos Health Inc. (COSM)vs › | $17.32M | 0.23 | 0.24 | 0.25 | 0.35 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.28M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.18M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $17.46M | 0.01 | 0.02 | 0.04 | 0.14 |
| PAVmed Inc. (PAVM)vs › | $17.23M | 153.88 | 160.63 | 60.23 | 135.95 |
| Lipocine Inc. (LPCN)vs › | $17.19M | 10.95 | 9.03 | 16.06 | 157.58 |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | 1.30 | 1.77 | 177.00 | 2050.99 |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.16M | N/A | 252.77 | 5169.56 | 5169.56 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 13.79 | 9.33 | 7.96 | 8.85 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from USD to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q2 FY2026Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q3 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q4 FY2026Period ended 2026-06-30 | $1,174,165 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-18 |
| TTM revenue | $1,174,165 |
Current P/S: $18,618,678 market capitalization ÷ $1,174,165 TTM revenue = 15.86x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:50:13.000Z. Latest revenue period ended 2026-06-30.
At 15.86, P/S is at an extreme level, where the multiple carries little signal — higher than 19% of readings in its estimated 5-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 5-year low
0.43
median
11298.76
estimated 5-year high
426448.25
P/S Ratio
15.86
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 15.90 |
| 2026-10-02 | 15.99 |
| 2026-10-01 | 16.18 |
| 2026-09-30 | 16.41 |
| 2026-09-29 | 16.45 |
| 2026-09-28 | 16.82 |
| 2026-09-25 | 16.82 |
| 2026-09-24 | 16.82 |
| 2026-09-23 | 16.96 |
| 2026-09-22 | 17.24 |
| 2026-09-21 | 17.10 |
| 2026-05-15 | 4.74 |
| 2026-05-14 | 5.10 |
| 2026-05-13 | 4.99 |
| 2026-05-12 | 4.94 |
| 2026-05-11 | 5.18 |
| 2026-05-08 | 5.32 |
| 2026-05-07 | 5.35 |
| 2026-05-06 | 5.39 |
| 2026-05-05 | 5.41 |
| 2026-05-04 | 5.30 |
| 2026-05-01 | 5.23 |
| 2026-04-30 | 5.28 |
| 2026-04-29 | 5.20 |
| 2026-04-28 | 5.13 |
| 2026-04-27 | 5.16 |
| 2026-04-24 | 5.05 |
| 2026-04-23 | 4.92 |
| 2026-04-22 | 4.94 |
| 2026-04-21 | 4.88 |
| 2026-04-20 | 5.04 |
| 2026-04-17 | 4.78 |
| 2026-04-16 | 4.73 |
| 2026-04-15 | 4.66 |
| 2026-04-14 | 4.72 |
| 2026-04-13 | 4.58 |
| 2026-04-10 | 4.79 |
| 2026-04-09 | 4.73 |
| 2026-04-08 | 4.71 |
| 2026-04-07 | 4.61 |
| 2026-04-06 | 4.33 |
| 2026-04-02 | 4.42 |
| 2026-04-01 | 4.13 |
| 2026-03-31 | 4.08 |
| 2026-03-30 | 3.95 |
| 2026-03-27 | 4.11 |
| 2026-03-26 | 4.21 |
| 2026-03-25 | 4.38 |
| 2026-03-24 | 4.52 |
| 2026-03-23 | 4.62 |
| 2026-03-20 | 4.62 |
| 2026-03-19 | 4.41 |
| 2026-03-18 | 4.58 |
| 2026-03-17 | 4.62 |
| 2026-03-16 | 4.60 |
| 2026-03-13 | 4.55 |
| 2026-03-12 | 4.74 |
| 2026-03-11 | 4.75 |
| 2026-03-10 | 4.66 |
| 2026-03-09 | 4.55 |
| 2026-03-06 | 4.33 |
| 2026-03-05 | 4.55 |
| 2026-03-04 | 4.65 |
| 2026-03-03 | 4.36 |
| 2026-03-02 | 4.27 |
| 2026-02-27 | 4.16 |
| 2026-02-26 | 4.37 |
| 2026-02-25 | 4.37 |
| 2026-02-24 | 4.40 |
| 2026-02-23 | 4.32 |
| 2026-02-20 | 4.36 |
| 2026-02-19 | 4.28 |
| 2026-02-18 | 4.43 |
| 2026-02-17 | 1.76 |
| 2026-02-13 | 1.75 |
| 2026-02-12 | 1.76 |
| 2026-02-11 | 1.74 |
| 2026-02-10 | 1.75 |
| 2026-02-09 | 1.73 |
| 2026-02-06 | 1.74 |
| 2026-02-05 | 1.73 |
| 2026-02-04 | 1.73 |
| 2026-02-03 | 1.74 |
| 2026-02-02 | 1.75 |
| 2026-01-30 | 1.74 |
| 2026-01-29 | 1.74 |
| 2026-01-28 | 1.74 |
| 2026-01-27 | 1.75 |
| 2026-01-26 | 1.75 |
| 2026-01-23 | 1.81 |
| 2026-01-22 | 1.80 |
| 2026-01-21 | 1.75 |
| 2026-01-20 | 1.74 |
| 2026-01-16 | 1.78 |
| 2026-01-15 | 1.77 |
| 2026-01-14 | 1.75 |
| 2026-01-13 | 1.80 |
| 2026-01-12 | 1.82 |
| 2026-01-09 | 1.81 |
| 2026-01-08 | 1.76 |
| 2026-01-07 | 1.72 |
| 2026-01-06 | 1.72 |
| 2026-01-05 | 1.66 |
| 2026-01-02 | 1.65 |
| 2025-12-31 | 1.68 |
| 2025-12-30 | 1.61 |
| 2025-12-29 | 1.63 |
| 2025-12-26 | 1.61 |
| 2025-12-24 | 1.64 |
| 2025-12-23 | 1.63 |
| 2025-12-22 | 1.69 |
| 2025-12-19 | 1.68 |
| 2025-12-18 | 1.68 |
| 2025-12-17 | 1.64 |
| 2025-12-16 | 1.69 |
| 2025-12-15 | 1.66 |
| 2025-12-12 | 1.77 |
| 2025-12-11 | 1.72 |
| 2025-12-10 | 1.82 |
| 2025-12-09 | 1.99 |
| 2025-12-08 | 1.96 |
| 2025-12-05 | 1.85 |
| 2025-12-04 | 1.85 |
| 2025-12-03 | 1.81 |
| 2025-12-02 | 1.89 |
| 2025-12-01 | 1.90 |
| 2025-11-28 | 1.96 |
| 2025-11-26 | 1.89 |
| 2025-11-25 | 1.97 |
| 2025-11-24 | 1.92 |
| 2025-11-21 | 1.93 |
| 2025-11-20 | 1.82 |
| 2025-11-19 | 1.91 |
| 2025-11-18 | 2.05 |
| 2025-11-17 | 2.03 |
| 2025-11-14 | 0.51 |
| 2025-11-13 | 0.51 |
| 2025-11-12 | 0.52 |
| 2025-11-11 | 0.52 |
| 2025-11-10 | 0.52 |
| 2025-11-07 | 0.44 |
| 2025-11-06 | 0.46 |
| 2025-11-05 | 0.47 |
| 2025-11-04 | 0.45 |
| 2025-11-03 | 0.47 |
| 2025-10-31 | 0.48 |
| 2025-10-30 | 0.47 |
| 2025-10-29 | 0.49 |
| 2025-10-28 | 0.50 |
| 2025-10-27 | 0.48 |
| 2025-10-24 | 0.66 |
| 2025-10-23 | 0.43 |
| 2025-10-22 | 0.46 |
| 2025-10-21 | 0.52 |
| 2025-10-20 | 1.64 |
| 2025-10-17 | 1.65 |
| 2025-10-16 | 1.62 |
| 2025-10-15 | 1.84 |
| 2025-10-14 | 1.71 |
| 2025-10-13 | 1.78 |
| 2025-10-10 | 1.86 |
| 2025-10-09 | 2.02 |
| 2025-10-08 | 1.96 |
| 2025-10-07 | 2.00 |
| 2025-10-06 | 2.13 |
| 2025-10-03 | 2.07 |
| 2025-10-02 | 1.56 |
| 2025-10-01 | 1.47 |
| 2025-09-30 | 1.26 |
| 2025-09-29 | 107.93 |
| 2025-09-26 | 112.03 |
| 2025-09-25 | 113.30 |
| 2025-09-24 | 104.20 |
| 2025-09-23 | 100.47 |
| 2025-09-22 | 89.73 |
| 2025-09-19 | 91.92 |
| 2025-09-18 | 85.55 |
| 2025-09-17 | 96.74 |
| 2025-09-16 | 113.85 |
| 2025-09-15 | 109.84 |
| 2025-09-12 | 118.40 |
| 2025-09-11 | 127.32 |
| 2025-09-10 | 126.68 |
| 2025-09-09 | 137.42 |
| 2025-09-08 | 118.22 |
| 2025-09-05 | 108.21 |
| 2025-09-04 | 108.48 |
| 2025-09-03 | 118.31 |
| 2025-09-02 | 108.75 |
| 2025-08-29 | 103.11 |
| 2025-08-28 | 111.12 |
| 2025-08-27 | 93.01 |
| 2025-08-26 | 75.26 |
| 2025-08-25 | 66.80 |
| 2025-08-22 | 65.34 |
| 2025-08-21 | 62.98 |
| 2025-08-20 | 63.16 |
| 2025-08-19 | 69.53 |
| 2025-08-18 | 70.89 |
| 2025-08-15 | 73.71 |
| 2025-08-14 | 73.71 |
| 2025-08-13 | 72.35 |
| 2025-08-12 | 66.98 |
| 2025-08-11 | 65.52 |
| 2025-08-08 | 67.62 |
| 2025-08-07 | 70.53 |
| 2025-08-06 | 71.35 |
| 2025-08-05 | 69.07 |
| 2025-08-04 | 70.80 |
| 2025-08-01 | 73.26 |
| 2025-07-31 | 73.81 |
| 2025-07-30 | 74.26 |
| 2025-07-29 | 77.90 |
| 2025-07-28 | 79.08 |
| 2025-07-25 | 77.35 |
| 2025-07-24 | 76.44 |
| 2025-07-23 | 74.62 |
| 2025-07-22 | 70.07 |
| 2025-07-21 | 70.07 |
| 2025-07-18 | 67.80 |
| 2025-07-17 | 68.16 |
| 2025-07-16 | 67.89 |
| 2025-07-15 | 68.80 |
| 2025-07-14 | 70.07 |
| 2025-07-11 | 69.98 |
| 2025-07-10 | 69.16 |
| 2025-07-09 | 67.89 |
| 2025-07-08 | 65.52 |
| 2025-07-07 | 65.16 |
| 2025-07-03 | 64.89 |
| 2025-07-02 | 63.89 |
| 2025-07-01 | 63.89 |
| 2025-06-30 | 64.61 |
| 2025-06-27 | 63.70 |
| 2025-06-26 | 61.88 |
| 2025-06-25 | 63.70 |
| 2025-06-24 | 56.42 |
| 2025-06-23 | 55.06 |
| 2025-06-20 | 61.88 |
| 2025-06-18 | 60.25 |
| 2025-06-17 | 61.52 |
| 2025-06-16 | 60.97 |
| 2025-06-13 | 62.07 |
| 2025-06-12 | 64.98 |
| 2025-06-11 | 65.07 |
| 2025-06-10 | 65.34 |
| 2025-06-09 | 62.07 |
| 2025-06-06 | 62.52 |
| 2025-06-05 | 65.07 |
| 2025-06-04 | 65.07 |
| 2025-06-03 | 62.34 |
| 2025-06-02 | 63.79 |
| 2025-05-30 | 60.52 |
| 2025-05-29 | 58.97 |
| 2025-05-28 | 59.34 |
| 2025-05-27 | 61.34 |
| 2025-05-23 | 61.70 |
| 2025-05-22 | 56.70 |
| 2025-05-21 | 50.33 |
| 2025-05-20 | 117.94 |
Showing the most recent 260 of 824 data points. The chart above shows the full history.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
